Bare-Metal Versus Drug-Eluting Stent Placement Among Patients Presenting With Anemia

JACC: Cardiovascular Interventions

Volumn 2, Issue 4, 2009, Pages 337-338

  Koul, Sharat ^a   Moliterno, David J ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

acute coronary syndromes; anemia; bare metal stents; drug eluting stents; hemoglobin; percutaneous coronary intervention

Indexed keywords

CANGRELOR; HEMOGLOBIN; PRASUGREL; TICAGRELOR;

ACUTE CORONARY SYNDROME; ANEMIA; BARE METAL STENT; DEATH; DRUG ELUTING STENT; EDITORIAL; HEART INFARCTION; HEMATOCRIT; HIGH RISK PATIENT; HUMAN; IN-STENT RESTENOSIS; MEDICAL DECISION MAKING; MORTALITY; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE HEMORRHAGE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; ST SEGMENT ELEVATION; STENT THROMBOSIS; SURVIVAL RATE; TREATMENT DURATION; TREATMENT OUTCOME;

ANEMIA; ANEMIA, MACROCYTIC; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; ERYTHROCYTE INDICES; HEMATOCRIT; HUMANS; METALS; RISK ASSESSMENT; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 64749107054     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.02.003     Document Type: Editorial

References (9)

1. Lee P.C., Kini A.S., Ahsan C., Fisher E., and Sharma S.K. Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol 44 (2004) 541-546
2. Sabatine M.S., Morrow D.A., Giugliano R.P., et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111 (2005) 2042-2049
3. Manoukian S.V., Feit F., Mehran R., et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial. J Am Coll Cardiol 49 (2007) 1362-1368
4. Kinnaird T.D., Stabile E., Mintz G.S., et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 92 (2003) 930-935
5. Ruiz-Nodar J.M., Marin F., Hurtado J.A., et al. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. J Am Coll Cardiol 51 (2008) 818-825
6. Serebruany V.L., Malinin A.I., Ferguson J.J., Vahabi J., Atar D., and Hennekens C.H. Bleeding risks of combination vs. single antiplatelet therapy: a meta-analysis of 18 randomized trials comprising 129,314 patients. Fundam Clin Pharmacol 22 (2008) 315-321
7. Shishehbor M.H., Filby S.J., Chhatriwalla A.K., et al. Impact of drug-eluting versus bare-metal stents on mortality in patients with anemia. J Am Coll Cardiol Intv 2 (2009) 329-336
8. Angiolillo D.J., and Guzman L.A. Clinical overview of promising nonthienopyridine antiplatelet agents. Am Heart J 156 (2008) S23-S28
9. Murphy S.A., Antman E.M., Wiviott S.D., et al., TRITON-TIMI 38 Investigators. Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial. Eur Heart J 29 (2008) 2473-2479